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Ethnopharmacological relevance: Species of Aristolochia are associated with aristolochic acid nephropathy
(AAN), a renal interstitial ﬁbrosis and upper urinary tract cancer (UUC). Aristolochic acid nephropathy
has been reported in ten countries but its true incidence is unknown and most likely underestimated.
By combining an ethnobotanical and phytochemical approach we provide evidence for the risk of AAN
occurring in Bangladesh. More speciﬁcally, we assess the intra-speciﬁc variation of aristolochic acid
analogues in medicinally used Aristolochia indica samples from Bangladesh.
Materials and methods: Ethnobotanical information was collected from 16 kavirajes (traditional healers)
in different study locations in Bangladesh. Plant samples were obtained from native habitats, botanical
gardens, herbal markets and pharmaceutical companies. The samples were extracted using 70%
methanol and were analysed using LC-DAD-MS and 1H-NMR.
Results: Roots as well as leaves are commonly used for symptoms such as snake bites and sexual problems.
Among the informants knowledge about toxicity or side effects is very limited and Aristolochia indica is often
administered in very high doses. Replacement of Aristolochia indicawith othermedicinal plants such as Rauvolﬁa
serpentina (L.) Benth. ex Kurz was common. Aristolochia indica samples contained a variety of aristolochic acid
analogues such as aristolochic acid I, aristolochic acid II, cepharadione A and related compounds.
Conclusions: AAN cases are likely to occur in Bangladesh and more awareness needs to be raised about
the health risks associated with the use of Aristolochia indica and other species of Aristolochia as herbal
medicines.
& 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY license.r Ireland Ltd.
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Species of Aristolochia are known to cause aristolochic acid
nephropathy (AAN), a renal interstitial ﬁbrosis, which is associated
with a high incidence of upper urinary tract cancer (UUC) (Nortier
et al., 2000). It was initially reported in a Belgian cohort of over
100 patients after the intake of slimming pills containing a Chinese
herb, Aristolochia fangchi Wu ex L.D. Chow & S.M. Hwang
(Vanherweghem, 1998). Following this tragic incidence, species
of Aristolochiawere banned in many countries, including Germany,
the UK, USA, Australia and Canada. However, drugs and medical
preparations from species of Aristolochia are used widely (and
often legally) in many countries and can be bought via the Internet
(Gold and Slone, 2003; Schaneberg and Khan, 2004; Heinrich
et al., 2009). So far AAN has only been reported in 15 countries but
its true incidence is unknown and probably underestimated
(National Toxicology Program, 2008).
Evidence for AAN being a major public health problem has only
been provided for two small regions worldwide, speciﬁcally the
Balkan region and Taiwan. In the Balkan region, the dietary intake
of ﬂour contaminated with Aristolochia clematitis L. seeds is
proposed as the environmental causal factor for Balkan Endemic
Nephropathy (BEN) (Grollman et al., 2007; Jelakovic et al., 2012).
This disease has affected thousands of patients in the Danube
basin and its clinical expressions and pathological lesions are
strikingly similar to AAN (De Broe, 2012). Furthermore, recent
research has shown that exposure to species of Aristolochia used in
traditional Chinese medicines contributes signiﬁcantly to the
incidence of upper urothelial cancer (UUC) in Taiwan (Chen
et al., 2012). However, it is likely that AAN and UUC are also
prevalent in other countries where species of Aristolochia are used
(Heinrich et al., 2009), creating a global public health problem of
considerable but largely unknown magnitude (Debelle et al., 2008;
Grollman et al., 2009; Grollman, 2013).
Ethnobotanical studies indicate that the Indian subcontinent is
one of the hot spots for Aristolochia use (Heinrich et al., 2009).
Aristolochia indica L. was found to be the most frequently cited
species in the literature. A possible association between chronic
interstitial ﬁbrosis in Indians and the intake of Aristolochia has
been proposed before (Vanherweghem, 1997; Debelle et al., 2008;
Grollman et al., 2009). Therefore, it is likely that the medicinal use
of Aristolochia indica results in a large number of undiagnosed AAN
and UUC cases on the Indian subcontinent.
This work focuses speciﬁcally on the uses of Aristolochia indica
in Bangladesh and their implications on public health. Bangladesh
was chosen as a case study since Aristolochia indica, the most
frequently cited Aristolochia species is native there. However, only
fewer ethnobotanical reports on Aristolochia indica uses exist in
comparison to India. While four species of Aristolochia are found in
Bangladesh (Aristolochia elegans Mast., Aristolochia indica L.,
Aristolochia saccata Wall. and Aristolochia acuminata Lam., Ahmed
et al., 2007), Aristolochia indica is the most widely distributed
species and has the greatest importance as a medicinal plant
(Heinrich et al., 2009; Mollik et al., 2010).
In Bangladesh only 1.5% of the gross national product (GNP) is
spent on health care (Rahman, 2005). Non-communicable dis-
eases including kidney disease are not priorities and patient care
is deﬁcient. The number of nephrologists in Bangladesh is limited
and renal disease care is only available in six public hospitals and
10 private hospitals (Rashid, 2004). An overburdened health-care
system with few renal facilities means that recording cases is not
a priority. Since there are few statistics regarding kidney disease
(Jha, 2009) it is not surprising that no records of AAN cases in
Bangladesh exist. In addition to limited data recording there is a
lack of knowledge regarding the condition and its causes.
Furthermore, the medical care offered is rarely integrated withherbal medicine and it is unlikely that the connection between
the use of Aristolochia as a medicine and kidney disease would to
be made.
The use of herbal medicine in Bangladesh is widespread with
estimates of up to 75% of the population using complementary and
alternative medicines to manage their health needs (Ghani and
Pasha, 2004). In addition to allopathic medicine a range of medical
practices exist (and overlap) in Bangladesh including Ayurvedic,
Unani, homoeopathy, popular and spiritual medicines. Kavirajes are
‘folk’ or ‘traditional’ healers that use plant preparations to treat
various ailments (Rahman et al., 2010). The practices of kavirajes
are varied as they draw on Ayurvedic, Unami and spiritual models of
healing (either in combination or exclusively). They are frequently
found across Bangladesh catering to the primary health care needs of
a large proportion of the population (Mollik et al., 2010).
The aim of this study was to assess the risk of AAN occurring in
Bangladesh by combining an ethnobotanical and phytochemical
approach. More speciﬁcally, we assessed the importance of Aris-
tolochia indica, its medicinal uses and the knowledge about the
health risks associated with its use by carrying out interviews
with healers (kavirajes) in different study locations in Bangladesh.
Furthermore, we studied the intraspeciﬁc phytochemical variation
of Aristolochia indica samples obtained in Bangladesh using
metabolomic methods based on LC-DAD-MS and 1H -NMR
(Michl et al., 2011). We especially focused on the content of
aristolochic acid analogues (AAAs), the group of compounds
known to be responsible for the nephrotoxic and carcinogenic
effects of Aristolochia species (National Toxicology Program, 2011;
Kumar et al., 2003).2. Materials and methods
2.1. Ethnobotanical survey
Prior to the start of the ﬁeldwork ethical approval was obtained
from the School of Pharmacy’s (University of London, UK) Ethics
Committee (January 2012).
Ethnobotanical information was collected during two ﬁeld
studies in February 2012 and August 2012. Semi-structured inter-
views were carried out with 16 healers (kavirajes) in different
study locations in Bangladesh (Rajshahi, Dhaka, Natore, Tangail,
Bandarban and Sylhet, Fig. 1) in order to obtain data representative
for the whole of Bangladesh. The interviews were carried out in
Bengali with the help of a translator and generally took place in
public spaces such as markets. Informant consent was obtained
prior to the interviews. However, the aims of the study relating to
the toxicity of Aristolochia indica could not be fully disclosed prior
to the interview. Informants were asked to list medicinal uses of
Aristolochia indica and were then asked to provide more detailed
information about these uses. The questions covered in the inter-
views included vernacular names of the species, the parts used
(leaves, roots, stems, fruits, seeds), the mode of preparation and
administration, dose, duration of treatment and knowledge about
toxicity or side effects. All informants were male, however they
belonged to different ethnic groups: Bengali (10), Marma (1),
Santal (2), Tripura (1), Mandai (1) and Bongshi (1). All informants
were asked whether they would be willing to provide a sample of
Aristolochia indica or to identify the plant in photographs if plant
material was not available.
2.2. Plant material and herbal formulations
Aristolochia indica samples were collected either in their
natural habitat or were obtained from botanical gardens. Voucher
specimens of samples 3 (J. Michl BI-21582) and 4 (J.Michl
Table 1
Information about ‘Ishwarmul’ samples obtained from Bangladesh or from the
Economic Botany Collection, Royal Botanic Gardens, Kew, UK (CP, commercial
product; MS, market sample; EBC, Economic Botany Collection).
Plant part Source Place of collection Voucher number
1 Stem Wild Tangail BI-21568
2 Leaf Wild Tangail BI-21580
Stem
Root
3 Leaf Cultivated Rajshahi BI-21582 (K)
Stem
Root
4 Leaf Cultivated Rajshahi BI-21583 (K)
5 Stem Cultivated Natore BI-21571
6 Stem Cultivated Natore BI-21572
7 Stem Cultivated Natore BI-21573
8 Stem Cultivated Rajshahi BI-21574
9 Fruit Cultivated Rajshahi BI-21584
10 Root MS Dhaka BI-21570
11 Root MS Natore BI-21569
12 Root MS Dhaka BI-21577
13 Root MS EBC (Sri Lanka) BI-21555, EBC-45619
14 Root MS EBC (India) BI-21553, EBC-45617
15 Root MS EBC (India) BI-21551, EBC-45616
16 Liquid formulation CP Rajshahi BI-21576
17 Liquid formulation CP Rajshahi BI-21585
18 Paste CP Tangail BI-21581
Fig. 1. Map of different study locations in Bangladesh.
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deposited in the Herbarium, Royal Botanic Gardens, Kew (RBG
Kew, UK). Root samples which were traded under the name
‘Ishwarmul' (a common name for Aristolochia indica) were pur-
chased from herbal markets. Further root samples were obtained
from the Economic Botany Collection (RBG Kew, UK). The identity
of these root samples was determined by their phytochemical
proﬁle. Commercial preparations obtained from phytopharmaceu-
tical companies or from kavirajes were included as well. These
preparations include two aqueous extracts, one semi-solid paste
used to prepare pills containing Aristolochia indica as well as a
variety of other plants such as Cinnamomum cassia L., Eclipta erecta
L. and Curcuma phaeocaulis Valeton. Three samples (4, 10 and 11,
Table 1) were extracted and analysed in triplicate in order to assess
the reproducibility of the extraction and processing method.
Information about the samples is shown in Table 1.2.3. Chemicals
All chemical reagents used were of analytical grade. Deuterated
water (D2O, 99.9%) and deuterated methanol (MeOD, 99.8%) were
obtained from Cambridge Isotope Laboratories, Inc. (Andover, MA).
3-(Tetramethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt (TSP,
98%) was obtained from Sigma–Aldrich (St. Louis, MO). Di-
potassium hydrogen orthophosphate (K2HPO4) and potassium
dihydrogen orthophosphate (KH2PO4) were obtained from BDH
Laboratory Supplies (Poole, UK).2.4. Preparation of extracts
The dried plant material was ground in a mortar and extracted
with 70% methanol in a microtube for 16 h (50 mg/ml).
The extracts were then centrifuged (10 min, 10 000 rpm) and
ﬁltered using a 0.45 mm PTFE ﬁlter. The liquid Ayurvedic formula-
tions (Samples 16–17) were ﬁltered using 0.45 mm PTFE ﬁlters and
the ﬁltrate was used for LC-MS analysis. An aliquot (700 ml) of each
extract or formulation was transferred to LC-MS vials.2.5. LC-DAD-MS analysis
The analysis was carried out using a Thermo Scientiﬁc LC-DAD-
ESI-MS system (Thermo Scientiﬁc, MA, USA) consisting of an
‘Accela’ liquid chromatograph with diode array detector and an
‘LTQ-Orbitrap XL’ hybrid linear ion trap-orbitrap mass spectro-
meter. Chromatography was performed on a 150 mm3 mm,
3 mm Phenomenex Luna C18 column using a 400 ml/min ﬂow rate.
The separation was obtained using the following linear mobile
phase gradient: 0 min: 90% A, 0% B, 10% C; 50 min: 0% A, 90% B, 10%
C, 55 min: 0% A, 90% B, 10% C, 57 min 90% A, 0% B, 10% C, 60 min
90% A, 0% B, 10% C (A: water, B: methanol, C: acetontirile contain-
ing 1% formic acid). The injection volume was 5 ml. Ammonia
solution was added post column at a ﬂow rate of 0.1 ml/min.
The mass spectrometer was ﬁtted with an electrospray source
(Thermo ‘Ion Max’) operated in positive mode at a source voltage
of 3.5 kV using sheath and auxiliary nitrogen ﬂow rates of 60 and
20 units, respectively, and a capillary temperature of 300 1C. High-
resolution MS1 scanning was performed in the orbitrap (m/z 250–
2000; resolution 30 000). Low-resolution data dependent MS2
and MS3 scans were undertaken in the linear ion trap (isolation
width 4 m/z units; collision energy 35%).2.6. 1H-NMR analysis
After LC-DAD-MS analysis the samples were dried at room
temperature and residual water was removed using lyophilisation.
The plant extracts were redissolved in 490 ml MeOD containing
0.01% TSP and 210 ml KH2PO4 buffer (pH¼6.0). The solutions were
transferred into 5 mm NMR tubes. 1H-NMR spectra were recorded
on a Bruker Avance 500 spectrometer operating at 500.13 MHz.
For each sample 256 transients were recorded as 65 K data points
with a spectral width of 10 330 Hz using 3.17 s acquisition time,
1.0 s relaxation delay, and a 301 pulse angle. FIDs were Fourier
transformed with LB¼0.3 Hz. The spectra were referenced to
internal TSP. 1H-NMR spectra were manually corrected for phase
and baseline distortions using Topspin (v 1.3., BrukerBiospin).
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The 1H-NMR spectra in the range of 0.1–10 ppm were divided
into 990 regions (“buckets”) of 0.01 ppm using AMIX software (v.
3.5.5.,BrukerBiospin) and the signal intensity in each region was
integrated. Water signals (4.65–5.15 ppm) and residual solvent
signals (3.25–3.4 ppm) were excluded. The data could then be
imported into Microsoft Excel for the addition of labels and
normalisation. The spectral areas were normalised to the total
sum of the spectral integral to avoid dilution effects.
Filtering, peak extraction, chromatogram de-convolution and peak
alignment of the high-resolution LC-MS data were performed auto-
matically using Mzmine 2 (http://mzmine.sourceforge.net). Peaks
between 2 and 40min retention time with a minimum peak intensity
of 500 000 and m/z between 250 and 650 were extracted. The
resulting data set was normalised to the total raw signal.
Principal component analysis (PCA) was carried out on the normal-
ised and pareto scaled dataset (for both, LC-MS and 1H-NMR data sets)
using the software SIMCA P+ (v. 12, Umetrics, Umea, Sweden).
For the analysis of aristolochic acid content peaks between
2 and 40 min retention time with a minimum peak intensity of
200 000 and m/z between 250 and 650 were extracted. The
dataset was not normalised.
2.8. Metabolite identiﬁcation assignment
For the peaks extracted by Mzmine 2, the ion species (i.e.
adduct) was determined so as to obtain an experimental accurate
molecular mass. This was then searched against the CRC Diction-
ary of Natural Products to identify candidate compounds having
molecular masses within 5 ppm of the experimental value. The
identity of characteristic biomarkers was veriﬁed using 2D –NMR
experiments (1H-1H J-RES, 1H-1H COSY, 1H-1H NOESY, 1H-13C
HMQC and 1H-13C HMBC) on selected samples. AA I, AA II, AA III,
AA IIIa, AA IV, AA D and AL I were identiﬁed by comparison to
reference standards. Further compounds were identiﬁed by com-
paring accurate mass data to an in-house database (UCL School of
Pharmacy, London, UK) consisting of 193 aristolochic acid analo-
gues that have previously been isolated from natural sources.
Putative assignments for those AAAs were made based on their
accurate mass, retention time, mass fragmentation and UV spectra.
3. Results and discussion
3.1. Importance of Aristolochia indica in Bangladesh
Aristolochia indica is widely available in herbal markets and the
majority of healers were knowledgeable about its medicinal uses (11
out of 16 kavirajes). Local names include ishwarmul, ghorth, tang gway
sobawai, and rudho jota (Table 2). While local names vary across ethnic
groups and between different regions of Bangladesh ishwarmul was
the most frequently reported local name. It is noteworthy that the
name ishwarmul is also used for other plants besides Aristolochia
indica, such as Pholidota pallida Lindl. (Orchidaceae).
Aristolochia indica is generally considered to be a very potent
medicinal plant. This is also reﬂected in the meaning of the Bengali
name ishwarmul, which can be translated as ‘god-given plant’.
Numerous myths and beliefs about the plant exist, most of them in
relation to snakes. One example is the belief that Aristolochia indica
growing in the garden prevents snakes from entering a house.
While the collection of Aristolochia indica in the wild seems to
be common, three informants reported that the plant is now very
rare. The fruits of Aristolochia indica were reported to be used as
food in the past, when the plant was commonly found in its
natural habitat. This reported use is particularly concerning, given
that it is likely that high doses were consumed and that fruits
often accumulate high amounts of aristolochic acid analogues.3.2. Medicinal uses
Ethnobotanical data were collected from 11 kavirajes. The healers
interviewed during this study came from a variety of ethnic back-
grounds and practiced different medical systems, such as Unani or
Ayurveda. All parts of the plant are used medicinally. A variety of
medicinal uses were reported for Aristolochia indica (Table 2). However
snake bites (5 use reports) was the most frequently reported use.
Other reported uses include sexual problems (3), gastric problems
(2) and the use as a tonic (2). Aristolochia species are used in childbirth
or as an abortifacient in many parts of the world, including Europe
(Heinrich et al., 2009). Interestingly, these uses were not reported by
any of the informants in this study.
3.3. Doses and formulations
Formulations and doses used are rarely reported in the ethnobota-
nical literature. However, due to the species’ toxic potential, detailed
records on the commonly used dose ranges were recorded. A variety of
doses and formulations were reported by the kavirajes (Table 2). In
terms of formulations, in most cases Aristolochia indica plant material
(roots, leaves or stems) was used directly rather than as an extract. The
most frequently reported formulationwas a pill made of different parts
of Aristolochia indica, often in combination with other plants such as
Asparagus racemosus Willd., Withania somnifera (L.) Dunal or Piper
nigrum L. and honey or sugar. Furthermore the use of pills contain-
ing Aristolochia indica in combination with chemicals obtained from
local markets was reported. The identity of these chemicals is
unknown but might be of toxicological concern, especially since
this formulation was used for pneumonia in children. Other
common formulations include the use of juice obtained from
Aristolochia indica roots or leaves or the intake of the plant powder
with small amounts of water. Interestingly, extraction of the plant
material using infusionwith water was only reported by one kaviraj.
However, phytopharmaceutical companies frequently manufacture
water extracts containing Aristolochia indica and a variety of other
medicinal plants according to Ayurvedic recipes.
The reported doses varied greatly. Extremely high doses were
reported, such as the use of 25–50 g of root powder against
snakebites or the ingestion of 3 g of root powder per day for one
month as a tonic. Furthermore, Aristolochia indica is sometimes
used for a long duration. One example is the use of 3 pills made of
Aristolochia indica leaves per day for 4 month against parasitic
worms. Assuming that one pill contains around 0.5 g of plant
material this results in an estimated total dose of 180 g. However,
in other cases the reported doses were extremely small or the
plant material was applied topically. One informant reported that
small pieces of roots are often worn around the neck in an amulet.
3.4. Reports of toxicity and side effects
In general knowledge about toxicity and side effects was very
limited (Table 2) and the majority of informants reported no side
effects or toxic effects (8 out of 11 kavirajes). Sleepiness, gastric
problems and rashes were reported as rare side effects occurring
in a few of the patients. Interestingly, one informant was aware of
toxic effects of Aristolochia indica leaves, but reported that the
roots of the plant are not toxic. However, none of the informants
reported nephrotoxicity as a risk resulting from the use of
Aristolochia indica as a herbal medicine.
3.5. Phytochemical variation in ‘Ishwarmul’ (Aristolochia indica and
other taxa) samples
We carried out a metabolomic study of Aristolochia indica
samples collected from their natural habitat or from botanical
Table 2
Medicinal use reports for Aristolochia indica.
Common
name
Medicinal use Plant
part
Formulation Dose and duration
of use
Side effects or
toxicity
Informant Location
Ishwarmul Gonorrhoea Root A paste made from Aristolochia indica (root), Rauvolﬁa serpentina
(L.) Benth. ex Kurz (root) and Curcuma longa L. (root)
1 g per day for
1 week
None Bengali Natore
Ishwarmul Snakebites Root Powder made from Aristolochia indica (root) and Rauvolﬁa
serpentina serpentina (L.) Benth. ex Kurz (leaf)
25–50 g taken at
once
None Bengali Natore
Antihelmintic Leaf A pill made from one leaf of Aristolochia incida and one clove
(Syzygium aromaticum (L.) Merr. & L.M. Perry )
3 Pills per day for
4 month
Leishmaniasis Leaf A pill made from two leaves of Aristolochia indica and two leaves
2 leaves of Andrographis paniculata (Burm. f.) Wall. ex Nees
3 Pills per day for
1 month
Rheumatic
fever
Leaf A pill made from two leaves of Aristolochia indica and two leaves
2 leaves of Andrographis paniculata (Burm. f.) Wall. ex Nees
2 pills per day for
2 days
Gastric
problems
Leaf A pill made from one leaf of Aristolochia incida and one clove
(Syzygium aromaticum (L.) Merr. & L.M. Perry). Taken with large
amounts of salt.
3 pills per day for
21 days
Madness Root A small piece of root is worn in an amulet around the neck 1 g
Dyspepsia Whole
plant
The whole plant is chopped into pieces. A paste is made with
sugar
3 pills per day for
21 days
Snakebites Leaf or
root
The roots or leaves of Aristolochia indica are combined with the
juice of Asparagus racemosus Willd. (root)
20 ml of juice
taken at once
Ishwarmul Neurotonic Root Aristolochia indica (root) and Withania somnifera (L.) Dunal
(root) are taken with milk
3 g per day for 30
days
Leaves may be
toxic, roots are
not toxic
Bengali Rajshahi
Neurotonic Root Powder taken with milk and honey 3 g per day for 30
days
Ishwarmul Analgetic Whole
plant
Powder 3 g taken 3 times
daily for 5–7 days
Gastric problems Bengali Rajshahi
Antibiotic Whole
plant
Powder 3 g taken 3 times
daily for 5–7 days
Snake bites Root Juice obtained for root 1 spoon per day
for 2 days
Oral infections Leaf Fresh leaves are applied topically 1–2 leaves for
7 days
Sexually
transmitted
diseases
Leaf A paste made from fresh leaves is applied topically 3 g for 30 days
Ishwarmul Madness Root Juice obtained from root 3 g for 7 days None Bengali Dhaka
Ishwarmul Sexual
problems
Root The root is made it into a paste with honey, as well as other
roots
3 pills for 14 days Allergic reactions
or rashes
Mandai Tangail
Sexual
problems
Leaf/
root
Juice is made from roots and leaves one spoonful
when necessary
Pneumonia Leaf/
root
Pills made from roots and leaves and two unknown chemicals 2 pills per day for
one month
Ishwarmul Rheumatic
arthritis
Root Pills made from root powder and honey 2 pills per day for
7–21 days
None Bongshi Tangail
Ghorth Snakebites Leaf Aristolochia indica leaves and 7–8 fruits of Piper nigrum L. are
made into pills
1 pill None Santal Rajshahi
Unconciousness Leaf Juice from leaves is dropped into the patients eyes 1–2 drops
Sexual
problems
Stem Juice from Aristolochia indica (stem) is combined with juice
Asparagus racemosus Willd. (root)
3 drops for 3 days
Ghorth Snakebites Root pills made of root powder and fruits of Piper nigrum L. 3 pills per day for
3 days
None Santal Rajshahi
Gastric
problems
Leaf Leaves are chewed 3–5 leaves when
necessary
Madness Root Root powder 1 gram per day
for one week
Madness Leaf Leaves are applied topically on the head 3–5 leaves
applied for 3–4 h
Tang gway
sobawai
Oedema Leaf/
root
Roots or leaves are heated to form a paste. The paste is applied
topically
5 g applied for up to
3 days
None Marma Bandarban
Jaundice Leaf/
root
Roots or leaves are heated to form a paste. The paste is applied
topically
5 g applied for up
to 3 days
Mosquito bites
or injuries
Leaf/
root
Roots or leaves are heated to form a paste. The paste is applied
topically
5 g applied for up
to 3 days
Ishramul Liver diseases Leaf Leaves are boiled with water 500 g in 1 l of
water, once a day
for 3 days
None Tripura Srimangal
Tonic Leaf Leaves are boiled with water 200 g in 2 l of
water, once a day
for 3 days
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Iswharmul’, and herbal formulations reported to contain
Aristolochia indica plant material were also included in the
analysis.The phytochemical variation of these samples was studied
using LC-MS and 1H-NMR. A three component PCA model
explained 39.8% of the variation in the LC-MS data set (Fig. 2a)
and 64.4% of the variation in the 1H-NMR data set (Fig. 2b).
Fig. 2. PCA scores plots based on LC-MS (a) and 1H-–NMR (b) data sets for all obtained ‘Ishwarmul’ samples (including herbal formulations 16, 17 and 18 and samples from
unknown species 8 11, 12 and 15). PCA scores plots showing the intraspeciﬁc variation in Aristolochia indica samples based on LC-MS (c) and 1H-NMR (d) data sets [data
normalised to the total raw signal, mean-centred and pareto scaled].
J. Michl et al. / Journal of Ethnopharmacology 149 (2013) 235–244240The PCA scores plot for the LC-MS data shows that the samples
are clustered into various groups. According to the loadings plot
only samples with negative PC1 scores (1, 2, 3, 4, 5, 6, 7, 9, 10, 13
and 14) were characterised by the presence of aristolochic acid I
(m/z 359.0870, tR¼35.93) and other aristolochic acid analogues.
This result suggests that not all analysed samples contained
Aristolochia indica plant material, even though they were traded
under the plants common name ‘Ishwarmul.’
Unsurprisingly, the three herbal formulations 16,17 (two liquid
water extracts obtained from phytoceutical companies) and 18
(a semi-solid paste for making pills obtained from a kaviraj) form a
cluster with positive PC1 scores in the LC-MS data set.
The formulations contain a variety of different herbs and are there-
fore not likely to contain high amounts of aristolochic acids.
Examination of the PCA loadings plots showed that the differentia-
tion is caused mainly by a variety of compounds with short retention
times (of which sucrose is likely to be a component of the
unretained peak at tR¼2.00 min giving [M+NH4]+ at m/z
360.1511). The 1H-NMR data loadings plot is characterised by a
variety of overlapping peaks in the carbohydrate region as well as
aromatic peaks corresponding to benzoic acid (δ 7.95 (dd, J¼7.5 Hz,
J¼1.5 Hz), δ 7.54 (t, J¼7.5 Hz), δ 7.45 (t, J¼7.5 Hz)). This compound
was presumably added to the liquid extracts as a preservative agent.
However, more surprisingly, samples 11 and 12, as well as
8 and 15 do not contain aristolochic acid analogues and form
clusters with positive PC1 scores in the LC-MS data set. Themetabolomic analysis indicates that these samples are from
another species, which has been misidentiﬁed as Aristolochia
indica or have been deliberately replaced. According to PC1 load-
ings plot (LC-MS data) samples 11 and 12 are characterised by
a peak giving [M+H]+ at m/z 349.1554 (tR¼17.93 min).. This ion
predicted a molecular formula of C21H20N2O3 that suggested
alstonine and/or its 20-epimer serpentine as candidates. The
1H-NMR peaks indicated by PCA analysis to be characteristic of
these root samples were in accordance with alstonine and ser-
pentine (Wachsmuth and Matusch, 2002). The two compounds
have almost identical 1H-NMR spectra (δ 8.51 (d, J¼6.5 Hz), δ 8.40
(d, J¼8.5 Hz), δ 8.37 (d, J¼6.6 Hz), δ 7.81 (d, J¼8.1), δ 7.76 (m) δ
7.75 (d, J¼1.4 Hz), δ 7.49 (m), δ 4.95 (m), δ 4.79 (m), δ 4.76 (dd,
J¼12.5, 5.5 Hz), δ 4.66 (m), δ 3.82 (s), δ 3.22 (d, J¼5.5 Hz), δ 3.15 (d,
J¼6.4 Hz), δ 2.82/δ 2.79 (m) and δ 1.38 (s)) apart from a small
difference in chemical shifts for H-20 (δ 2.81 vs. δ 2.79). A plant
commonly used for snakebites, insomnia and insanity in Ayurvedic
medicine is Rauvolﬁa serpentina (L.) Benth. ex Kurz (Keshavan,
2011). Local names in Bangladesh include chandramul and sarpa-
gandha. The presence of alstonine and serpentine in samples 11
and 12 would be consistent with roots of this species.
Samples 8 and 15 have very similar phytochemical proﬁles but do
not contain Rauvolﬁa alkaloids or aristolochic acid analogues. This
indicates that these samples belong to a, third unidentiﬁed species.
LC-MS total ion chromatograms and 1H-NMR spectra repre-
sentative for the different groups of samples (Aristolochia indica
Fig. 3. LC-MS total ion current chromatograms and 1H-NMR spectra for samples 3 (leaf) (a, b), 11 (root) (c, d) and 16 (liquid formulation) (e, f) [AAI, aristolochic acid I; AAD,
aristolochic acid D; ALIG, aristolactam I N-β-D-glucoside; BA, benzoic acid; S, serpentine; A, alstonine].
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and are shown in Fig. 3.
The result of the metabolomic analysis indicates that replace-
ments or misidentiﬁcations of plant species occur frequently in
Bangladesh. It also highlights that metabolomic analysis is a suitable
tool for the authentication of herbal medicines, allowing the
identiﬁcation of replacements or contaminated plant material.
3.6. Intraspeciﬁc variation in Aristolochia indica samples
Samples 8, 11, 12, 15, 16, 17 and 18 were removed from the analysis
and a PCA model of the remaining samples was calculated based on
their LC-MS and 1H-NMR data (Fig. 2c and d). A 3-component PCA
model explained 58.2% of the variation in the LC-MS dataset and 59.8%of the variation in the 1H-NMR dataset. Samples 1 (stem), 2 (leaf), 2
(stem), 3 (leaf) and 4 (leaf) are shown as outliers in the PCA scores plot
of the LC-MS data set. While the cluster consisting of samples 1 (stem),
3 (leaf) and 4 (leaf) was characterised by high amounts of aristolochic
acid I ([M+NH4]+, m/z 359.0870, tR¼35.93 min), aristolactam I N-β-D-
glucoside ([M+H]+, m/z 456.1285, tR¼26.53 min) and aristolactam I
([M+H]+, m/z 294.0759, tR¼36.18 min), samples 2 (stem) and 2 (leaf)
had high amounts of aristolochic acid II (tR¼34.09 min,m/z 329.0766).
It is noteworthy that these outliers consisted of fresh, green plant
material. In contrast, samples, which were obtained from older, woody
stems or roots (2, 3, 5, 6, 7, 10, 13 and 14) were located in the centre of
the scores plot. These samples were characterised by smaller
amounts of aristolochic acid analogues and a major metabolite giving
m/z 342.1706 (tR¼7.38 min). Among the possible candidate
Table 3
Retention times, UV maxima and fragmentation ions of identiﬁed aristolochic acid analogues. The compounds are sorted by descending average peak areas across all
samples.
No. Compound Retention time (min) [M+H]+ (m/z) [M+NH4]+ (m/z) Fragmentation ions (m/z)c UV maxima (nm)
1 Aristolochic acid Ia 35.93 359.0870 324, 296, 294, 268 252, 320,392
2 Aristolochic acid IIa 34.09 329.0766 294, 268, 250, 238 250, 300, 356
3 Cepharadione Ab 33.61 306.0759 288, 278, 248, 220 238, 301, 314,439
4 Aristolactam I; N-β-D-glucopyranosideb 26.53 456.1285 438, 336, 294, 279 237, 259, 291, 330, 403
5 Aristolactam AIIb 266.0808 251, 223, 195 239, 275, 314, 388
6 Aristolochic acid IVa 38:29 389.0987 326, 311, 283 237, 327, 405
7 Aristolactam IIIb 29.60 294.0758 279,251 244, 316, 450
8 Aristolochic acid Da 30.37 375.0821 357, 312, 297, 267 238, 329, 408
9 Aristolactam Ia 36.18 294.0759 279, 251 236, 291, 328, 391
10 Aristolochic acid IIIaa 27.41 345.0713 327, 310, 284, 254 235, 306, 400
11 Aristolactam IVab 39.42 310.0706 292, 277 240, 286, 298, 344, 420
12 Aristolactam AIIIb 29.44 296.0912 278, 263, 250 237, 278, 391
13 Aristoloterpenate Ib 25.01 558.2112 342, 297, 265 235, 279, 396
14 Aristolactam II; N-β-D-glucopyranosideb 25.22 426.1180 408, 306, 264, 234 235, 265, 277, 288, 327, 391
15 Ariskanin Bb 21.12 344.0768 327, 309 235, 280, 426
16 9-Methoxyaristolactam IIb 26.21 294.0757 279, 251 235, 272, 491
17 Aristolactam IIb 34.73 264.0654 234, 206 235, 277, 325, 374, 392
18 Aristolactam IIIa; N-β-D-glucopyranosideb 22.58 442.1130 424, 322, 280, 250 237, 258, 293, 326, 403
19 Norcepharadione Ab 31.60 292.0601 274, 264, 246 235, 280, 439
20 Aristolactam Ia; N-β-D-glucopyranosideb 16.35 442.1130 424, 322, 280, 222 234, 266, 283, 336, 403
21 Aristolochic acid Iab 30.76 345.0717 327, 310, 284, 254 235, 320, 392
a Identiﬁed by comparison with reference standard.
b Tentative assignment based on accurate mass, UV spectra and mass fragmentation.
c Fragmentation ions were extracted from MS2 and MS3 scans.
Fig. 4. Heat map comparing relative LC-MS peak areas of identiﬁed aristolochic acid analogues. Information about the origin of the samples is given in Table 1.
The compounds are sorted by descending average peak areas across all samples [a identiﬁed by comparison with reference standard; b tentative assignment based on
accurate mass, UV spectra and mass fragmentation].
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1.8 ppm) is the aporphine derivatives magnoﬂorine. The compound
showed the same MS/MS spectrum as the ion assigned to M+ of
magnoﬂorine in an LC-MS analysis of a leaf extract of Magnolia
grandiﬂora L. held in the analytical archives at RBG Kew.
These results suggest that the intraspeciﬁc variation in the
phytochemical proﬁle Aristolochia indica samples is inﬂuenced by
factors such as the age of the plant and the plant part used.3.7. Variation in aristolochic acid analogue content
Several aristolochic acid analogues were revealed by the
LC-DAD-MS analyses and these were either identiﬁed by compar-
ison with standards or given tentative assignments from their
accurate mass, fragmentation ions and UV spectra (Table 3 and
Fig. 4). Aristolochic acid I had the highest average peak area across
all samples, followed by aristolochic acid II and cepharanone A.
J. Michl et al. / Journal of Ethnopharmacology 149 (2013) 235–244 243Other common aristolochic acid analogues include aristolactam I
N-β-D-glucopyranoside, aristolochic acid V, aristolactam I, aristo-
lochic acid IIIa and aristolochic acid D.
Based on the sum of their peak areas sample 13 (root) has the
highest total amount of aristolochic acid analogues. While this
sample contains low amounts of AA I and AA II it contains a large
variety of aristolochic acid analogues, which are not present in any
other sample. Possible candidates for these compounds include
aristolactam AII, aristolactam III, aristolactam IVa and aristolactam
AIII. In general, root samples contained a wider variety of different
aristolochic acid analogues compared to other plant parts.
Sample 9 (fruit) had the second highest overall aristolochic acid
content. However, this is due to its extremely high contents of
aristolochic acid I and II. This may indicate that Aristolochia indica
fruits accumulate high amounts of aristolochic acid analogues.
The content of aristolochic acids analogues also varied greatly
between different parts of a single plant. For samples 2 and 3, leaf,
stem and root material from the same plant were analysed.
Interestingly sample 2 (leaf) did not contain aristolochic acid I,
whereas the root and stem of the same plant did. While in sample
3 all parts of the plant contained high amounts of aristolochic
acid I, the highest quantity was found in the leaf sample. Leaves,
fruits and young stems contain signiﬁcantly higher amounts of
aristolochic acid I and II than roots and woody stems (average sum
of peak areas 2.78108 vs. 4.86108, po0.05).
3.8. Toxicological risk assessment based on ethnobotanical and
phytochemical evidence
The toxicological risk that is posed by the consumption of
Aristolochia indica as a herbal medicine is dependent on a variety
of factors. In relation to drug preparation, which used these factors
include the dose, the mode of administration and the processing
method of the plant material. Other factors such as the time of
plant collection or interactions with other drugs that are taken
simultaneously might have minor inﬂuences on the toxicological
risk. Additionally the phytochemistry of the plant material is an
important factor that determines the toxicological risk associated
with the intake of Aristolochia indica. Besides the amount, the type
of aristolochic acids that are present also is important, given that
the toxicity of aristolochic acid analogues varies greatly
(Balachandran et al., 2005; Li et al., 2010).
In this study, the use report with the highest reported dose was
200 g of Aristolochia indica leaves soaked in 1 l of water, taken once
a day for 3 days, resulting in a total estimated dose of 600 g of
Aristolochia indica leaves. However, the fact that aristolochic acids
are very apolar compounds has to be considered. Kite et al. (2002)
showed that the relative amount of AA I in a water extract is less
than 6% compared to a 70% methanol extract. Therefore the
amount of aristolochic acid analogues present in a water extract
is comparatively low, and as a result the toxicological risk of this
formulation is reduced. On the other hand the use of Aristolochia
indica powder was reported in estimated total doses as high as
90 g of powder. In these cases the toxicity of the plant is not
reduced due to its processing method. In addition, the age of the
plant material inﬂuences the toxicological risk. Aristolochic acid
(I and II) contents in fruit, leaves and young stems are higher and
young plants can therefore be associated with higher toxicological
risk. It is noteworthy that some of the doses reported in this study
are comparable to the cumulative doses, which were reported for
patients of the Belgian cohort who developed urothelial carcinoma
after taking Chinese slimming pills (around 200 g of Aristolochia
fangchi Wu ex L.D. Chow & S.M. Hwang) (Nortier et al., 2000).
A cumulative dose of 200 g of A. fangchi contains approximately
130 mg aristolochic acid. Furthermore this study showed that
replacements of Aristolochia indica with other medicinal plantssuch as Rauvolﬁa serpentina (L.) Benth. ex Kurz are common.
Therefore it is likely that the problem exists vice versa. I.e.
Aristolochia indica plant material is used as a replacement for
other herbal medicines.
Taking this into consideration it is extremely likely that
aristolochic acid nephropathy cases have occurred in Bangladesh
and that AAN is an overlooked public health problem.4. Conclusions
AAN and aristolochic acid associated UUC has been identiﬁed
as an important health risk in some countries, but the wide
distribution of the genus globally requires a systematic assessment
of regions where AAN or UUC may be of concern. Here we
demonstrate that Aristolochia indica is widely available on herbal
markets and through healers’ networks in Bangladesh, a country
from which so far no cases of AAN have been reported. Our results
indicate that knowledge among kavirajes about the health risks
associated with its use is extremely limited.
Using a novel approach of directly combining an ethnobotani-
cal study with a metabolomic analysis we were able to provide an
assessment of potential risks associated with the use of Aristolochia
indica in Bangladesh. Based on the data obtained using this
ethnobotanical–phytochemical approach it is likely that aristolochic
acid nephropathy cases occur in Bangladesh creating an important
public health problem. Consequently future research needs to focus
on an epidemiological assessment of AAN and UUC in populations
potentially at risk in Bangladesh.
This work also highlights that awareness needs to be raised
about the health risks associated with the use of Aristolochia indica
and that there is a need for intervention by public health
authorities. Since Aristolochia species are commonly used in many
parts of the world including India, Africa and Central America, it is
likely that so far their effects on public health in these regions have
been overlooked. Therefore, this case study has wider implications
and should be expanded to other countries.
There is a need to carefully study supply and value chains in
herbal medicines and the impact this has on the products
composition, quality and safety (Booker et al., 2012). Overall, this
study demonstrates the value of using an ethnopharmacological
approach combining ethnobotanical ﬁeldwork with a metabolomic
analysis in addressing one of the key concerns in the area of
medicinal plant research – the exposure of endogenous toxins found
in a few taxa commonly used local and traditional medical systems.Acknowledgements
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